TEGA Therapeutics
PrivateLast Round
Grant
Dec 15, 2020
Total Funding Raised
$2.85M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TEGA Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in December 2020.
TEGA Therapeutics is a biotechnology company that develops glycoscience-based therapies and recombinant heparan sulfate reagents to treat lysosomal storage disorders and other life-threatening diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TEGA Therapeutics Comparables
Compare TEGA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glycan Therapeutics | 84% | |
| Sussex Research Laboratories Inc. | 77% | |
| GlycoT Therapeutics | 77% |
For institutional investors. Book with your work email.
TEGA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 15, 2020 | ||||
| Grant | Jul 31, 2019 | ||||
| Grant | Jan 31, 2019 | ||||
| Grant | Jul 20, 2018 | ||||
| Grant | Sep 14, 2015 |
For institutional investors. Book with your work email.
TEGA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sea Purity Investments | VC Round |
| TCA Venture Group | VC Round |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 50% MoM.
- Dec 15, 2020
$1.4M grant from the National Science Foundation.
For institutional investors. Book with your work email.
TEGA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TEGA Therapeutics's valuation, stock price, and market status.
Is TEGA Therapeutics a public or private company?
TEGA Therapeutics is a private company.
What is the current stock price of TEGA Therapeutics?
TEGA Therapeutics is a private company, so its shares have no public market price. Caplight tracks TEGA Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TEGA Therapeutics worth (valuation)?
Valuation information for TEGA Therapeutics is not publicly available.
Can I buy TEGA Therapeutics stock?
TEGA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TEGA Therapeutics's last funding round?
TEGA Therapeutics's most recent funding round was Grant on December 15, 2020.
Who are the main investors in TEGA Therapeutics?
Key investors in TEGA Therapeutics include Sea Purity Investments, TCA Venture Group, National Science Foundation.
Will TEGA Therapeutics IPO soon?
No public IPO plans have been announced for TEGA Therapeutics.
How can I track TEGA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in TEGA Therapeutics's shares on secondary markets.